Form 4: Delek US Director Sells 5,000 Shares Under 10b5-1 Plan

Delek US Holdings Director William J. Finnerty sold 5,000 shares of common stock for $47.50 per share, executed under a pre-arranged 10b5-1 trading plan.

Summary

• William J. Finnerty, a Director of Delek US Holdings, Inc. (DK), sold 5,000 shares of common stock.
• The transaction occurred on March 27, 2026, at a price of $47.50 per share.
• Following this sale, Mr. Finnerty beneficially owns 36,369 shares of Delek US Holdings common stock.
• The sale was executed pursuant to a Rule 10b5-1 trading plan, indicating it was pre-scheduled.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event. While an insider sale can sometimes be a negative signal, the execution under a pre-arranged 10b5-1 plan mitigates concerns about its implications for the company's immediate prospects.

Positives

• The transaction was executed under a Rule 10b5-1 plan, which suggests a pre-scheduled sale rather than a reaction to new, non-public information.

Negatives

• A director selling shares, even under a 10b5-1 plan, reduces their direct ownership in the company.

Future Outlook

No specific future outlook or guidance is provided in this Form 4 filing.

Industry Context

StockSavvy.ai notes that insider transactions, particularly sales, are routinely monitored by investors for signals regarding management's confidence. However, sales executed under a 10b5-1 plan are generally viewed with less concern as they are pre-arranged and not typically indicative of new, adverse information.

Related Party Transactions

• Director William J. Finnerty, a related party, sold 5,000 shares of Delek US Holdings, Inc. common stock.

Stakeholder Impact

• Shareholders: The sale by a director, even if pre-planned, slightly reduces insider ownership, which some shareholders might view as a minor negative.

Key Dates

Recommendation

The sale by a director under a pre-arranged 10b5-1 plan is a routine event and does not typically provide new fundamental information to warrant a change in investment thesis. Investors should continue to hold based on broader company fundamentals rather than this specific insider transaction.

Keywords

Delek US Holdings, DK, Form 4, Insider Trading, Stock Sale, Director, 10b5-1 Plan, Equity Transaction